Form 4: ARS Pharmaceuticals Director Peter Thompson Sells Shares

Director Peter Thompson reported selling 83,695 shares of ARS Pharmaceuticals (SPRY) common stock on August 26, 2024.

Summary

• On August 26, 2024, Peter A. Thompson, a director of ARS Pharmaceuticals, Inc. (SPRY), sold 83,695 shares of common stock.
• The sale price was $13 per share, with prices ranging from $12.59 to $13.35.
• Following the transaction, Thompson continues to indirectly hold shares through various entities including OrbiMed Partners Master Fund Limited, OPI VI IP HoldCo LLC, and OrbiMed Private Investments VI, LP.
• Thompson disclaims beneficial ownership of these shares except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of a stock sale by a company director. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders (officers, directors, or those holding more than 10% of a company's shares) buy or sell their company's stock. These filings provide transparency to the market regarding insider transactions.

Stakeholder Impact

• The stock sale by a director could be perceived negatively by some shareholders, potentially leading to a slight decrease in stock price, although the impact is likely to be minimal given the relatively small number of shares sold compared to the total outstanding.

Key Dates